tiprankstipranks
Novacyt (NVYTF)
OTHER OTC:NVYTF

Novacyt (NVYTF) Stock Price & Analysis

9 Followers

NVYTF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.45 - $1.03
Previous Close$0.5
Volume91.00
Average Volume (3M)1.80K
Market Cap
$55.53M
Enterprise Value-$53.14M
Total Cash (Recent Filing)£87.17M
Total Debt (Recent Filing)£872.00K
Price to Earnings (P/E)-1.2
Beta0.75
Sep 26, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.43
Shares Outstanding70,626,248
10 Day Avg. Volume0
30 Day Avg. Volume1,800
Standard Deviation0.34
R-Squared0.00690
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)33.55
Price to Sales (P/S)10.04
Price to Cash Flow (P/CF)-289.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.50%0.03%0.03%99.44%
0.50%
Insiders
0.03% Other Institutional Investors
99.44% Public Companies and
Individual Investors

NVYTF FAQ

What was Novacyt’s price range in the past 12 months?
Novacyt lowest stock price was $0.45 and its highest was $1.03 in the past 12 months.
    What is Novacyt’s market cap?
    Currently, no data Available
    When is Novacyt’s upcoming earnings report date?
    Novacyt’s upcoming earnings report date is Sep 26, 2024 which is in 131 days.
      How were Novacyt’s earnings last quarter?
      Currently, no data Available
      Is Novacyt overvalued?
      According to Wall Street analysts Novacyt’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Novacyt pay dividends?
        Novacyt does not currently pay dividends.
        What is Novacyt’s EPS estimate?
        Novacyt’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Novacyt have?
        Novacyt has 70,626,250 shares outstanding.
          What happened to Novacyt’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Novacyt?
          Currently, no hedge funds are holding shares in NVYTF
          ---

          Company Description

          Novacyt

          Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. Its diagnostic products are used in LBC, oncology, microbiology, hematology, and serology testing. The company operates its business through two business segments: Corporate and Diagnostics and Molecular Products.The Corporate and Diagnostics segment corresponds to diagnostic activities in laboratories, and the manufacturing and distribution of reagents and kitsfor bacterial and blood tests. The Molecular Products segment represents the activities of Primerdesign, which designs, manufactures and distributes test kits for certaindiseases in humans, animals and food products.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Advaxis
          Aptose Biosciences
          Compugen
          Cyclacel Pharmaceuticals
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis